RT Journal Article
SR Electronic
T1 Multiomic analysis reveals cellular and epigenetic plasticity in intestinal pouches of ulcerative colitis patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.11.11.23298309
DO 10.1101/2023.11.11.23298309
A1 Zhao, Yu
A1 Zhou, Ran
A1 Xie, Bingqing
A1 Liu, Cambrian Y
A1 Kalski, Martin
A1 Cham, Candace M
A1 Koval, Jason
A1 Weber, Christopher R
A1 Rubin, David T
A1 Sogin, Mitch
A1 Crosson, Sean
A1 Huang, Jun
A1 Fiebig, Aretha
A1 Dalal, Sushila
A1 Chang, Eugene B
A1 Basu, Anindita
A1 Pott, Sebastian
YR 2023
UL http://medrxiv.org/content/early/2023/11/13/2023.11.11.23298309.abstract
AB Background & Aims Total proctocolectomy with ileal pouch anal anastomosis (IPAA) is the standard of care for patients with severe treatment resistant ulcerative colitis (UC). Despite improvements in patient outcomes, about 50% of patients will develop inflammation of the pouch within 1-2 years following surgery. Establishment of UC pouches is associated with profound histological changes of the mucosa. A detailed characterization of these changes on a cellular and molecular level is crucial for an improved understanding of pouch physiology and diseases management.Methods We generated cell-type-resolved transcriptional and epigenetic atlases of UC pouches using scRNA-seq and scATAC-seq data from paired biopsy samples from the ileal pouch and ileal segment above the pouch (pre-pouch) of UC-IPAA patients (n=6, female=2) without symptoms. We also collected data from paired biopsies of the terminal ileum (TI) and ascending colon (AC) from healthy controls (n=6, female=3).Results We identified novel populations of colon-like absorptive and secretory epithelial cells, constituting a significant proportion of the epithelial cell fraction in the pouch but not in matched pre-pouch samples. Pouch-specific enterocytes expressed colon-specific genes, including CEACAM5, CA2. However, in contrast to normal colonic epithelium, these cells also expressed a range of inflammatory and secretory genes, similar to previously detected gene expression signatures in IBD patients. Comparison to longitudinal bulk RNA-seq data from UC pouches demonstrated that colon-like epithelial cells are present early after pouch functionalization and independently of subsequent pouchitis. Finally, single cell chromatin accessibility revealed activation colonic transcriptional regulators, including CDX1, NFIA, and EHF.Conclusion UC pouches are characterized by partial colonic metaplasia of the epithelium. These data constitute a resource of transcriptomic and epigenetic signatures of cell populations in the pouch and provide an anchor for understanding the underlying molecular mechanisms of pouchitis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded in part though grants from the National Institutes of Health R35GM142986 (to S.P.), RC2DK122394, T32DK007074, P30DK042086 and a grant from the GI Research Foundation (to E.B.C.), and a grant from The Leona M. and Harry B. Helmsley Charitable Trust to the University of Chicago.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was conducted under the translational core research program protocol (15573A), approved by the Institution Review board of University of Chicago. Licensed gastroenterologists collected biopsy samples and clinical data from patients identified as UC-pouch and non-IBD control subjects. Biopsy sample and patients demographic data were obtained from all participants with signed informed consent. Samples and demographic data were anonymized.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced are available online at GEO (GSE242087) https://github.com/EthanZhaoChem/Code_documentation_2023_IBD_pouch_paper https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE242087